10-27092420-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_014915.3(ANKRD26):​c.624A>G​(p.Val208Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.199 in 1,607,082 control chromosomes in the GnomAD database, including 38,653 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.24 ( 4875 hom., cov: 32)
Exomes 𝑓: 0.20 ( 33778 hom. )

Consequence

ANKRD26
NM_014915.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -1.38

Publications

28 publications found
Variant links:
Genes affected
ANKRD26 (HGNC:29186): (ankyrin repeat domain containing 26) This gene encodes a protein containing N-terminal ankyrin repeats which function in protein-protein interactions. Mutations in this gene are associated with autosomal dominant thrombocytopenia-2. Pseudogenes of this gene are found on chromosome 7, 10, 13 and 16. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
ANKRD26 Gene-Disease associations (from GenCC):
  • thrombocytopenia 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • acute myeloid leukemia
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • autosomal thrombocytopenia with normal platelets
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary thrombocytopenia and hematologic cancer predisposition syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BP6
Variant 10-27092420-T-C is Benign according to our data. Variant chr10-27092420-T-C is described in ClinVar as Benign. ClinVar VariationId is 260473.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.38 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.537 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANKRD26NM_014915.3 linkc.624A>G p.Val208Val synonymous_variant Exon 4 of 34 ENST00000376087.5 NP_055730.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANKRD26ENST00000376087.5 linkc.624A>G p.Val208Val synonymous_variant Exon 4 of 34 5 NM_014915.3 ENSP00000365255.4

Frequencies

GnomAD3 genomes
AF:
0.235
AC:
35778
AN:
151946
Hom.:
4853
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.310
Gnomad AMI
AF:
0.177
Gnomad AMR
AF:
0.198
Gnomad ASJ
AF:
0.205
Gnomad EAS
AF:
0.553
Gnomad SAS
AF:
0.387
Gnomad FIN
AF:
0.257
Gnomad MID
AF:
0.180
Gnomad NFE
AF:
0.164
Gnomad OTH
AF:
0.223
GnomAD2 exomes
AF:
0.242
AC:
59829
AN:
247536
AF XY:
0.244
show subpopulations
Gnomad AFR exome
AF:
0.312
Gnomad AMR exome
AF:
0.195
Gnomad ASJ exome
AF:
0.217
Gnomad EAS exome
AF:
0.549
Gnomad FIN exome
AF:
0.253
Gnomad NFE exome
AF:
0.164
Gnomad OTH exome
AF:
0.208
GnomAD4 exome
AF:
0.195
AC:
284013
AN:
1455018
Hom.:
33778
Cov.:
31
AF XY:
0.199
AC XY:
144413
AN XY:
724138
show subpopulations
African (AFR)
AF:
0.305
AC:
10143
AN:
33308
American (AMR)
AF:
0.194
AC:
8628
AN:
44540
Ashkenazi Jewish (ASJ)
AF:
0.215
AC:
5605
AN:
26076
East Asian (EAS)
AF:
0.578
AC:
22881
AN:
39596
South Asian (SAS)
AF:
0.364
AC:
31298
AN:
86014
European-Finnish (FIN)
AF:
0.250
AC:
13244
AN:
52984
Middle Eastern (MID)
AF:
0.217
AC:
1168
AN:
5378
European-Non Finnish (NFE)
AF:
0.161
AC:
178014
AN:
1106996
Other (OTH)
AF:
0.217
AC:
13032
AN:
60126
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
9727
19454
29182
38909
48636
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6746
13492
20238
26984
33730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.236
AC:
35847
AN:
152064
Hom.:
4875
Cov.:
32
AF XY:
0.245
AC XY:
18188
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.310
AC:
12866
AN:
41446
American (AMR)
AF:
0.197
AC:
3013
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.205
AC:
711
AN:
3472
East Asian (EAS)
AF:
0.554
AC:
2855
AN:
5154
South Asian (SAS)
AF:
0.385
AC:
1857
AN:
4824
European-Finnish (FIN)
AF:
0.257
AC:
2716
AN:
10570
Middle Eastern (MID)
AF:
0.170
AC:
50
AN:
294
European-Non Finnish (NFE)
AF:
0.164
AC:
11125
AN:
67998
Other (OTH)
AF:
0.233
AC:
493
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1325
2650
3974
5299
6624
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
382
764
1146
1528
1910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.187
Hom.:
9723
Bravo
AF:
0.232
Asia WGS
AF:
0.465
AC:
1615
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Thrombocytopenia 2 Benign:3
Nov 22, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 08, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.20
DANN
Benign
0.52
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2297145; hg19: chr10-27381349; COSMIC: COSV108209677; COSMIC: COSV108209677; API